Binding and lysing of blood clots using MRX-408

Investigative Radiology

Volumn 33, Issue 12, 1998, Pages 880-885

  Wu, Yunqiu ^a   Unger, Evan C ^a,b   McCreery, Thomas P ^a   Sweitzer, Robert H ^a   Shen, Dekang ^a   Wu, Guanli ^a   Vielhauer, Matthew D ^a  

^a ImaRx Therapeutics Inc   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

Author keywords

Contrast agent; Drug delivery; Microbubbles; Thrombolysis; Ultrasound

Indexed keywords

CONTRAST MEDIUM; MRX 408; PHOSPHOLIPID; UNCLASSIFIED DRUG; UROKINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD CLOT LYSIS; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DOG; ECHOGRAPHY; MICROSCOPY; NONHUMAN; PRIORITY JOURNAL; THROMBUS; ULTRASOUND THERAPY;

EID: 0032471036     PISSN: 00209996     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004424-199812000-00006     Document Type: Article

References (15)

1. Francis C, Önundarson P, Carstensen E, et al. Enhancement of fabrinolysis in vitro by ultrasound. J Clin Invest 1992;90:2063-2068.
2. Tachibana K. Enhancement of fibrinolysis with ultrasound energy. J Vasc Interven Radiol 1992;3:299-303.
3. Tachibana K, Tachibana S. Albumin microbubble echo-contrast material as an enhancer for ultrasound-accelerated thrombolysis. Circulation 1995;92:1148-1150.
4. Nilsson AM, Odselius R, Roijer A, Olsson SB. Pro- and antifibrinolytic effects of ultrasound on streptokinase-induced thrombolysis. Ultrasound Med Biol 1995;21:833-840.
5. Luo H, Nishioka T, Fishbein M, et al. Transcutaneous ultrasound augments lysis of arterial thrombi in vivo. Circulation 1996;94: 775-778.
6. Luo H, Steffen W, Cercek B, Arunasalam S, Maurer G, Siegel R. Enhancement of thrombolysis by external ultrasound. Am Heart J 1993;125:1564-1569.
7. Nishioka T, Luo H, Fishbein M, et al. Dissolution of thrombotic arterial occlusion by high intensity, low frequency ultrasound and dodecafluoropentane emulsion: An in vitro and in vivo study. J Am Coll Cardiol 1997;30:561-568.
8. Porter T, LeVeen R, Fox R, Kricsfeld A, Xie F. Thrombolytic enhancement with perfluorocarbon-exposed sonicated dextrose albumin microbubbles. Am Heart J 1996;132:964-968.
9. Porter T, Iverson P, Li S, Xie F. Interaction of diagnostic ultrasound with synthetic oligonucleotide-labeled perfluorocarbon- exposed sonicated dextrose albumin microbubbles. J Ultra Med 1996;15: 577-584.
10. Unger EC, McCreery TP, Sweitzer RH, Shen D, Wu G. In vitro studies of a new thrombus-specific ultrasound contrast agent. Am J Cardiol 1998;81(suppl 12A):56G-61G.
11. Takeuchi M, McCreery TP, Ogunyankin K, et al. A new tissue-targeted ultrasound contrast agent, MRX-408, improves visualization and delineation of left atrial appendage clot with conventional two-dimensional echocardiography. J Am Coll Cardiol 1998; 31(suppl A):400A.
12. Metzger P, Unger EC. Using MRX-408 to detect thrombi in AV fistulae. 3rd Ultrasound Contrast Research Symposium in Radiology Applications, Quantitation, & Instrumentation. San Diego, CA: 1998. Abstract.
13. Wu Q, Unger EC, McCreery TP, Veilhauer MD, Sweitzer RH. Imaging and lysing of blood clots - results of MRX-408 with an imaging and therapy apparatus. 3rd Ultrasound Contrast Research Symposium in Radiology Applications, Quantitation, & Instrumentation. San Diego, CA: 1998. Abstract.
14. Unger EC, Fritz TA, McCreery TP, et al. Liposomes as myocardial perfusion ultrasound contrast agents. In: Goldberg B, ed. Ultrasound contrast agents. London: Martin Dunitz Ltd., 1997;57-74.
15. Chandler AB. In vitro thrombotic coagulation of the blood: A method for producing thrombus. Lab Invest 1958;7:110-114.